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ABSTRACT
Introduction On 1 October 2015, the USA transitioned
from the International Classification of Diseases, 9th
Revision, Clinical Modification (ICD-9-CM) to the
International Classification of Diseases, 10th Revision
(ICD-10-CM). Considering the major changes to drug
overdose coding, we examined how using different
approaches to define all-drug overdose and opioid
overdose morbidity indicators in ICD-9-CM impacts
longitudinal analyses that span the transition, using
emergency department (ED) and hospitalisation data
from six states’ hospital discharge data systems.
Methods We calculated monthly all-drug and opioid
overdose ED visit rates and hospitalisation rates (per
100 000 population) by state, starting in January 2010.
We applied three ICD-9-CM indicator definitions that
included identical all-drug or opioid-related codes but
restricted the number of fields searched to varying
degrees. Under ICD-10-CM, all fields were searched
for relevant codes. Adjusting for seasonality and
autocorrelation, we used interrupted time series models
with level and slope change parameters in October 2015
to compare trend continuity when employing different
ICD-9-C
 M definitions.
Results Most states observed consistent or increased
capture of all-drug and opioid overdose cases in ICD10-CM coded hospital discharge data compared with
ICD-9-CM. More inclusive ICD-9-CM indicator definitions
reduced the magnitude of significant level changes, but
the effect of the transition was not eliminated.
Discussion The coding change appears to have
introduced systematic differences in measurement
of drug overdoses before and after 1 October 2015.
When using hospital discharge data for drug overdose
surveillance, researchers and decision makers should be
aware that trends spanning the transition may not reflect
actual changes in drug overdose rates.

INTRODUCTION
Background

Epidemiologists and researchers have historically
relied on International Classification of Diseases
(ICD) coded emergency department (ED) and
hospitalisation administrative claims data reported
through state-level hospital discharge data (HDD)
systems to track drug overdose trends.1–9 The
transition from the ICD 9th Revision, Clinical

Modification (ICD-9-
CM) to the 10th Revision
(ICD-10-CM) on 1 October 2015 marked a major
change in medical claims coding for all USA healthcare entities covered by the Health Insurance Portability and Accountability Act.10–12
The number of injury and poisoning diagnosis
codes increased from 2600 in ICD-9-CM to 43 000
in ICD-10-CM, greatly improving code specificity.
ICD-10-CM also streamlined the coding process by
incorporating both drug and intent (unintentional,
intentional self-
harm, assault and undetermined)
information into a single code. In ICD-9-
CM,
overdose visits were coded with a diagnosis code
indicating the drug involved and/or a separate
non-
billable external cause of injury code indicating intentionality.13 14 Though these are positive
changes for drug overdose surveillance, the extensive revisions preclude a simple one-to-one crosswalk between the ICD-9-
CM and ICD-10-
CM
coding systems and raise questions about how best
to track overdose trends over time using claims
data.10–13
Two recent studies examined opioid overdose
trends across the ICD transition using inpatient data
from the Healthcare Cost and Utilization Project,
finding that hospitalisations mentioning an opioid
overdose code in any field decreased by 10.2% and
12.4% from 2015 Q3 (last quarter of ICD-9-CM)
to 2015 Q4 (first quarter of ICD-10-CM).15 16 The
reported decreases, however, could be because
both studies excluded assault and intentional self-
harm codes from their ICD-10-CM indicator but
not their ICD-9-CM indicator.15 16 Other studies
employing ICD-9-
CM-
based drug overdose indicators,1–8 as well as guidance from the Council of
State and Territorial Epidemiologists (CSTE) and
CDC,9 17–19 vary in terms of which ICD-9-CM codes
are included and which fields are searched for relevant codes. In ICD-10-CM, CSTE and CDC recommendations agree that all available fields should be
searched for overdose indicator codes.17 18 20 21
To the best of our knowledge, this study is the
first to use interrupted time series (ITS) methodology to analyse the performance of all-drug and
opioid overdose indicators across the ICD transition
in both ED and inpatient datasets. ITS methodology
accounts for pre-
existing trends, seasonality and
autocorrelation,22 23 which were not addressed by
previous trend analysis studies.15 16 It is important
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Interrupted time series analysis to evaluate the
performance of drug overdose morbidity indicators
shows discontinuities across the ICD-9-CM to ICD-10-
CM transition
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Objectives

The purpose of this study is to examine trends in nonfatal all-
drug and opioid overdose indicators across the ICD-9-CM to
ICD-10-CM transition using ED and hospitalisation data from
six states (Kentucky, Missouri, Montana, Nevada, New Mexico
and Tennessee). Three different ways of defining all-
drug
and opioid overdose indicators in ICD-9-CM were tested to
compare trend continuity with ICD-10-CM-based definitions.
It was hypothesised that using the most inclusively structured
indicator definitions in both coding schemas would minimise
discontinuity in all-drug and opioid overdose trends that span
the transition.

METHODS
Data source and study population

States participating in the CSTE Drug Poisoning Indicators
Workgroup (DPI-WG) were eligible to participate in the study
if their state HDD system captured both ED visit and hospital
inpatient administrative claims data from 2010 to at least 2016.
State HDD systems are based on the nationally standardised
Uniform Billing 2004 (UB-04) form, which is completed by
licenced medical coders for reimbursement purposes. Thus,
HDD is high-quality, population-based and comparable across
states, making it an important public health surveillance data
source. State HDD typically includes demographic information,
several fields for ICD diagnosis, external cause and procedure
codes, and payment source for every patient discharged from
an acute care facility in the state, although federal and specialty
hospitals are often exempt from reporting.24 UB-04 coding rules
state that for inpatient admissions, the first-listed code should
capture the ‘principal diagnosis’, or main diagnosis necessitating
inpatient care as determined by the attending medical provider.
For ED visits, the term ‘first-listed’ is used in lieu of ‘principal’

Table 1

since oftentimes providers do not reach a confirmed diagnosis in
the ED setting.25 26
In this study, each state’s ED visit and hospitalisation datasets were analysed separately. ED visits resulting in admission
were included in the hospitalisation dataset only. Interfacility
transfers and repeat visits for the same overdose event were
not excluded because no personal identifiers were available.
Records from federal, specialty or other non-acute care facilhospital deaths and out-
ities were excluded, along with in-
of-
state residents. All records containing at least one drug
overdose ICD-9-CM (discharge date before 1 October 2015) or
ICD-10-CM code (discharge date on or after 1 October 2015)
(listed in 17 18 20 21) in any field were included in the analytic
datasets.

Case definitions
For ICD-9-CM coded data, we explored three different ways
CM definition
of defining each indicator. The first ICD-9-
required one of the included ICD-9-CM diagnosis codes to be
present in the principal/first-listed diagnosis field or one of the
included ICD-9-CM external cause codes to be the first-listed
valid external cause code (included codes are listed in table 1)
(definition 1). This definition structure was recognised by Injury
Surveillance Workgroup (ISW) 7 as a conservative option for
identifying poisoning cases and was used by CDC for state injury
indicator reporting prior to 2015.9 19 The second ICD-9-CM
definition required an included diagnosis code to be present in
the principal/first-listed diagnosis field or an included external
cause code to be listed anywhere in the record (definition 2).
Both CDC and CSTE used this definition structure for reporting
CM coded data.17 18 The third
opioid overdoses in ICD-9-
ICD-9-CM definition required at least one included ICD-9-CM
code to be listed anywhere in the record (definition 3). This definition structure, also known as ‘any mention’, was recognised
by ISW 7 as the most inclusive option for identifying poisoning
cases in ICD-9-CM coded data.19 For ICD-10-CM coded data,
‘any mention’ of at least one of the included ICD-10-CM diagnosis codes was required (table 1).17 18 20 21

ICD-9-CM and ICD-10-CM codes included in all-drug overdose and opioid overdose indicators

Indicator

ICD-9-CM codes

All-drug overdose

Diagnosis codes

ICD-10-CM codes
960–979: poisoning by drugs, medicinal and
biological substances.

Diagnosis codes

T36-T50: poisoning by drugs, medicaments and biological
substances
(code must have an intent character of 1 (accidental/
unintentional), 2 (intentional self-harm), 3 (assault) or
4 (undetermined) and a seventh character of A (initial
encounter) or missing).

Diagnosis codes

T40.0X: poisoning by opium.
T40.1X: poisoning by heroin.
T40.2X: poisoning by other opioids.
T40.3X: poisoning by methadone.
T40.4X: poisoning by synthetic narcotics.
T40.60: poisoning by unspecified narcotics.
T40.69: poisoning by other narcotics.
(code must have an intent character of 1 (accidental/
unintentional), 2 (intentional self-harm), 3 (assault) or
4 (undetermined) and a seventh character of A (initial
encounter) or missing).

External cause codes E850-E858: accidental poisoning by drugs, medicinal
and biological substances.
E950.0-E950.5: suicide and self-inflicted poisoning
by solid or liquid substances.
E962.0: assault by drugs and medicinal substances
E980.0-E980.5: poisoning by solid or liquid
substances undetermined whether accidentally or
purposely inflected.
Opioid overdose

Diagnosis codes

965.00: poisoning by opium.
965.01: poisoning by heroin.
965.02: poisoning by methadone.
965.09: poisoning by other opiates and related
narcotics.

External cause codes E850.0: accidental poisoning by heroin.
E850.1: accidental poisoning by methadone.
E850.2: accidental poisoning by other opiates and
related narcotics.

ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification; ICD-10-CM, International Classification of Diseases, 10th Revision, Clinical Modification.
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for stakeholders relying on longitudinal data to understand that
CM presents opportunities for improved drug
while ICD-10-
overdose surveillance, the new coding scheme essentially constitutes an instrument change and could affect epidemiological
analysis of temporal trends that span October 2015.

Original research
Characteristics of participating states’ datasets
Hospitalisation dataset

ED visit dataset

Postintervention time
points (months)

Diagnosis code
fields

External cause
code fields

Diagnosis code
fields

External cause
code fields
3

State

Date range analysed

Preintervention time
points (months)

Kentucky

January 2010–June 2018

69

33

25

3

25

Missouri

January 2010–December 2017

69

27

23

1

23

1

Montana

January 2010–December 2017

69

27

9

3

9

3

New Mexico

January 2010–December 2017

69

27

18

3

48

6

Nevada

January 2010–December 2016

69

15

33

4

33

4

Tennessee

January 2010–December 2017

69

27

18

3

18

3

ED, emergency department.

Study design and analytic plan

Each state generated monthly counts of all-drug and opioid overdose ED visits and hospitalisations using the three ICD-9-CM
indicator definitions for records with a discharge date before 1
October 2015 and the ICD-10-CM definition for records with a
discharge date on or after 1 October 2015. To account for population changes over time, monthly crude rates per 100 000 population were generated and used as model outcome variables.27
ITS methods were used to examine how all-drug and opioid
overdose indicators performed over time, with an interruption
point at October 2015.22 28–30 The study period spanned from
January 2010 to the most recent year of data available, which
varied by state (table 2). We modelled each state’s pretransition
overdose trends so that the trends observed after the transition
could be compared with the ‘counterfactual’, or the expected
ongoing trend if ICD-10-CM had never been introduced. Inclusion of at least 12 time points before and after the transition
allowed for evaluation of monthly seasonality.22 28 29 We calculated segmented regression models that included both a level
and a slope change parameter using the following autoregressive
error linear regression model22 23 31:
Yt = β0 + β1 × Timet + β2 × Transitiont + β3 × TimeAfterTransitiont + vt 

vt = −φ1 vt−1 − φ1 vt−1 − ... − φk vt−k + εt 
	
	

(
)
εt ∼ IN 0, σ 2


Where:
Yt =overdose morbidity rate at time (t).
β0=intercept.
β1=pretransition slope.
β2=
 immediate effect of transition.
β
=
3
  post-transition slope change.
vt =autoregressive error term of order k at time (t).
εt =error at time (t), independently normally distributed with
mean=0 and variance=σ 2.
The Intercept parameter (β0) represents the estimated all-drug
or opioid overdose ED visit or hospitalisation rate per 100 000
population at time (t)=0 (January 2010). The β1 parameter
models the slope (average monthly change) in overdose rate
during ICD-9-
CM (January 2010–September 2015). Time is
coded as 1 for the first time point (January 2010) increasing
sequentially through the last time point in the study (ie, 96 for
December 2017). The β2parameter represents a change in level
between the time points immediately before and after the transition, controlling for the pretransition trend. Transition is a
dummy variable coded 0 for all time points before the transition and 1 for October 2015 onward. A positive β2 coefficient,
Yang H, et al. Inj Prev 2021;27:i35–i41. doi:10.1136/injuryprev-2019-043522

or ‘positive level change’, is interpreted as an abrupt increase
in overdose rate in October 2015 that is inconsistent with the
existing ICD-9-CM trend. A negative β2coefficient, or ‘negative
level change’, is interpreted as an abrupt decrease in October
2015 that is inconsistent with the existing ICD-9-CM trend. The
β3 parameter models the difference between the pretransition
and post-transition slopes. TimeAfterTransition is an interaction
term between Time and Transition. Adding coefficients β1 + β3
yields the post-transition slope, or average monthly change in
overdose rate after October 2015.22 28–31
Overdose morbidity rates were tested for seasonality using SAS
PROC X12, after accounting for length-of-month variation.32
If seasonality was identified, multiplicative decomposition was
used to seasonally adjust the data.33 SAS PROC AUTOREG with
the BACKSTEP option was used to select the correct model by
sequentially eliminating autoregressive terms not statistically
significant at the 0.05 level from an initial full model with order
(k)=13.32 If the final model contained autoregressive terms, we
reported the maximum likelihood estimates with autoregressive
parameters assumed given. Model fit was assessed by examining
residual plots, white noise probabilities, autocorrelation functions and partial autocorrelation functions.23 32 P values less than
0.05 were considered statistically significant. We performed
sensitivity analyses by testing models that only included a level
change parameter, and using different approaches to adjust for
seasonality.22 23 33 The findings were consistent with those from
the primary analysis. All analyses were performed using SAS
software V.9.4.32 It was not appropriate or possible to involve
patients or the public in the design, conduct, reporting or
dissemination plans of our research.

RESULTS
All-drug overdose results
Intercept

For all-drug overdose ED visits, ICD-9-CM definition 3 resulted
in the highest intercept estimate compared with definitions 1 and
2 in all states except Nevada. The largest difference was seen in
Kentucky, where the estimated all-drug overdose ED visit rate in
January 2010 was 4.1% higher using definition three compared
with definition 1. Similarly, for all-drug overdose hospitalisations, definition 3 resulted in the highest intercept estimates
compared with definitions 1 and 2 in all states except Montana.
For hospitalisations, the largest difference was seen in Nevada,
where the estimated rate in January 2010 was 5.9% higher using
definition three compared with definition 1 (table 3).

Time

Trends in all-drug overdose ED visit rates and hospitalisation
rates prior to the transition (January 2010–September 2015)
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Table 2

Original research

ED visit regression parameters

State

ICD-9-CM all-drug overdose
indicator definition†

Intercept‡

Kentucky

Definition 1

10.88*

Missouri

Montana

New Mexico

Nevada

Tennessee

Time§
0.10*

Transition¶
0.97

Hospitalisation regression parameters

TimeAfterTransition** Intercept Time
0.09

11.17*

−0.01

Transition
2.00*

TimeAfterTransition
−0.05

Definition 2

10.91*

0.11*

0.55

0.10

11.23*

−0.01

1.69*

−0.05

Definition 3

11.33*

0.10*

0.68

0.09

11.64*

−0.01

1.90*

−0.05*

Definition 1

13.21*

−0.02*

2.19*

0.06

11.26*

−0.02*

0.65*

−0.02

Definition 2

13.23*

−0.02*

1.79*

0.07*

11.49*

−0.02*

0.69*

−0.02

Definition 3

13.46*

−0.02*

1.81*

0.07*

11.61*

−0.02*

0.61*

−0.02

Definition 1

11.78*

0.00

1.74

0.08

9.95*

−0.01*

0.38

0.04

Definition 2

11.86*

0.00

1.65

0.08

10.09*

−0.02*

0.48

0.03

Definition 3

12.19*

0.00

1.39

0.08

9.88*

0.00

−0.54

0.03

Definition 1

21.11*

−0.01

−1.54

−0.11

12.60*

−0.05*

1.07*

0.03

Definition 2

21.50*

−0.01

−1.16

−0.13

12.82*

−0.06*

0.94*

0.04

Definition 3

21.58*

0.01

−2.77*

−0.13

13.07*

−0.06*

0.75

0.04

Definition 1

16.64*

−0.03*

−0.49

0.14

8.92*

−0.01

−0.14

0.03

Definition 2

16.80*

−0.03*

−0.58

0.14

9.00*

0.00

−0.31

0.03

Definition 3

16.75*

−0.02

−1.24

0.09

9.45*

−0.01

−0.43

Definition 1

16.62*

−0.01

0.94

0.11*

9.46*

0.00

1.57*

−0.06*

Definition 2

16.80*

−0.01

0.86

0.11*

9.59*

0.00

1.45*

−0.06*

Definition 3

16.96*

−0.01

0.62

0.11*

9.71*

0.00

1.31*

−0.06*

0.04

Statistically significant results are marked with * (α=0.05).
†ICD-9-CM all-drug overdose indicator definitions (used prior to 1 October 2015): definition 1 searched the principal/first-listed diagnosis and first-listed valid external cause fields, definition 2
searched the principal/first-listed diagnosis and all external cause fields and definition 3 searched all available fields for the presence of an included code.
‡Intercept – estimated rate in January 2010.
§Time: average monthly change in rate (slope) from January 2010 to September 2015.
¶Transition: immediate level change observed in October 2015.
**TimeAfterTransition: change in slope after October 2015 compared with the pretransition slope.
ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification.

varied by state, regardless of the ICD-9-CM indicator definition applied. For example, Kentucky saw increasing ED visit
rates and stable hospitalisation rates during ICD-9-CM, while
Missouri observed declining overdose rates for both ED visits
and hospitalisations (table 3).

Transition
For all-drug overdose ED visits, four states (Kentucky, Montana,
Nevada and Tennessee) did not observe a level change at the
time of the ICD transition. Missouri saw a positive level change
that was largest with definition 1. In New Mexico, there was
no level change using definitions 1 and 2 and a negative level
change using definition 3. For all-drug overdose hospitalisations,
two states (Montana and Nevada) did not observe a level change
at the transition, while the remaining four states (Kentucky,
Missouri, New Mexico and Tennessee) had positive level changes
that were smallest using definition 3 (table 3).

TimeAfterTransition
For all-drug overdose ED visits, Missouri had a positive slope
change after the ICD transition when using definitions 2 and 3,
and Tennessee observed a positive slope change regardless of the
ICD-9-CM definition used. For all-drug overdose hospitalisations, Kentucky observed a negative slope change following the
ICD transition when using definition 3, and Tennessee observed
a negative slope change with all the ICD-9-
CM definitions
(table 3).
See online supplementary appendices 1 and 2 for graphs of the
predicted versus observed all-drug overdose ED visit and hospitalisation rates in each state.
i38

Opioid overdose results
Intercept

For opioid overdose ED visits, ICD-9-CM definition 3 resulted
in the highest intercept estimate compared with definitions 1 and
2 in five states (Missouri, Montana, New Mexico, Nevada and
Tennessee). The largest difference was seen in Tennessee where
the estimated opioid overdose ED visit rate in January 2010 was
55.1% higher using definition 3 compared with definition 1.
For opioid overdose hospitalisations, definition 3 resulted in the
highest intercept estimates compared with definitions 1 and 2 in
all states. The largest difference was seen in Kentucky where the
estimated rate in January 2010 was 61.3% higher using definition 3 compared with definition 1 (table 4).

Time

Four states (Kentucky, Missouri, New Mexico and Tennessee)
observed positive slopes in their opioid overdose ED visit rates
during ICD-9-
CM regardless of which ICD-9-
CM definition
was applied. For opioid overdose hospitalisations, Tennessee
observed no slope, meaning that rate was stable from January
2010 to September 2015. New Mexico observed a negative
slope with all three ICD-9-CM definitions, while Nevada had a
negative slope with definition 3 (table 4).

Transition

All participating states observed positive level changes immediately following the ICD transition for opioid overdose ED visits
as well as hospitalisations. Using definition 1 to capture cases in
ICD-9-CM resulted in the largest positive level change, while
definition 3 resulted in the smallest level change. In New Mexico
and Nevada, the positive level change in opioid overdose ED
Yang H, et al. Inj Prev 2021;27:i35–i41. doi:10.1136/injuryprev-2019-043522
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Table 3 Interrupted time series model regression parameters: all-drug overdose emergency department (ED) visit and hospitalisation rates per
100 000 population using three different ICD-9-CM indicator definitions

Original research

ED visit regression parameters

Hospitalisation regression parameters

State

ICD-9-CM opioid
overdose indicator
definition†
Intercept‡

Kentucky

Definition 1

0.54

0.07*

5.08*

−0.02

1.73*

Definition 2

0.61

0.07*

4.99*

−0.02

1.99*

Definition 3

1.04

0.07*

4.71*

−0.01

Definition 1

1.59*

0.02*

1.38*

Definition 2

1.66*

0.02*

Definition 3

1.89*

Definition 1

Missouri

Montana

New Mexico

Nevada

Tennessee

Transition

TimeAfter-
Transition

0.00

1.56*

−0.03*

0.00

1.37*

−0.03*

2.79*

0.00

0.63*

−0.02

0.05*

1.59*

0.00

1.36*

−0.02*

1.33*

0.05*

1.76*

0.00

1.20*

−0.02*

0.02*

1.10*

0.05*

2.26*

0.00

0.67*

−0.02*

0.98*

0.00

0.68*

0.01

1.25*

0.00

0.74*

0.00

Definition 2

1.03*

0.00

0.63*

0.01

1.29*

0.00

0.64*

0.00

Definition 3

1.33*

0.00

0.45*

0.01

1.81*

0.00

0.29

0.00

Definition 1

3.40*

0.01*

1.20*

0.00

2.10*

−0.01*

1.44*

−0.02*

Definition 2

3.49*

0.01*

0.84

0.02

2.30*

−0.01*

1.30*

−0.02*

Definition 3

3.91*

0.02*

−0.06

0.01

2.95*

−0.01*

0.76*

−0.02

Definition 1

2.27*

0.00

0.86*

0.01

1.87*

0.00

1.17*

−0.01

Definition 2

2.57*

0.00

0.75*

0.01

2.09*

0.00

0.92*

0.00

Definition 3

3.06*

0.00

0.27

0.01

2.69*

−0.01*

0.55*

0.01

Definition 1

1.27*

0.01*

1.48*

0.10*

1.60*

0.00*

1.34*

−0.02*

Definition 2

1.46*

0.01*

1.35*

0.10*

1.91*

0.00*

1.10*

−0.02*

Definition 3

1.97*

0.01*

0.97*

0.10*

2.48*

0.00

0.64*

−0.02*

Time§

Transition¶

TimeAfter-
Transition**

Intercept

Time

Statistically significant results are marked with * (α=0.05).
†ICD-9-CM all-drug overdose indicator definitions (used prior to 1 October 2015): definition 1 searched the principal/first-listed diagnosis and first-listed valid external cause
fields, definition 2 searched the principal/first-listed diagnosis and all external cause fields and definition 3 searched all available fields for the presence of an included code.
‡Intercept: estimated rate in January 2010.
§Time: average monthly change in rate (slope) from January 2010 to September 2015.
¶Transition: immediate level change observed in October 2015.
**TimeAfterTransition: change in slope after October 2015 compared with the pretransition slope.
ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification.

visits completely disappeared using definition 3 and similarly in
Montana for opioid overdose hospitalisations (table 4).

TimeAfterTransition

The change in slope of opioid overdose ED visits and hospitalisations after the transition varied by state without a clear pattern.
Missouri and Tennessee observed increases in ED visit slope during
ICD-10-
CM compared with ICD-9 CM, while for hospitalisations, Kentucky, Missouri, New Mexico and Tennessee observed
negative post-transition slope changes (table 4).
See online supplementary appendices 3 and 4 for graphs of the
predicted versus observed opioid overdose ED visit and hospitalisation rates in each state.

DISCUSSION
Key results

In this study, we used ITS analysis to examine how the transition
from ICD-9-CM to ICD-10-CM impacts surveillance of all-drug
and opioid overdose morbidity trends. We tested several ways
of structuring indicators in ICD-9-CM, yet discontinuities were
present even when using ‘any mention’ definitions in both coding
systems and controlling for pre-existing overdose morbidity trends
in each state. Our findings suggest that the coding change on 1
October 2015 introduced systematic differences in measurement
of all-drug and opioid overdose ED visits and hospitalisations.
The most common type of trend discontinuity observed was a
sudden uptick in overdose case capture on ICD-10-CM implementation (positive level change). This could be related to the
major expansion of available codes in ICD-10-CM. In addition,
the shift to coding overdoses with a single diagnosis code in
Yang H, et al. Inj Prev 2021;27:i35–i41. doi:10.1136/injuryprev-2019-043522

ICD-10-CM, rather than a combination of diagnosis and external
cause codes, could systematically increase in case capture under
CM in jurisdictions with low external cause coding
ICD-10-
rates.14 31 34 The observed trend discontinuities could also reflect
actual shifts in the underlying incidence of overdoses.
Adjusting the number of diagnostic fields searched without
changing any of the codes included in ICD-9-
CM indicator
definitions influenced the magnitude and direction of trend
discontinuities seen in October 2015, when using the standardised ICD-10-CM ‘any mention’ definitions issued by CDC
and CSTE.18 20 21 ICD-9-
CM ‘any mention’ definitions consistently increased capture of drug overdose cases compared with
ICD-9-CM definitions that searched only specific fields. For states
that observed positive level changes, using the ICD-9-CM ‘any
mention’ definition either narrowed or closed the gap between
lower rates during the final month of ICD-9-
CM (September
2015) and higher rates first month of ICD-10-CM (October 2015),
which was consistent with our original hypothesis. This phenomenon was consistently more pronounced for the opioid overdose
indicator than the all-drug overdose indicator. We are unsure why
the ICD-9-CM ‘any mention’ definition captured more all-drug
overdose cases than the ICD-10-CM ‘any mention’ definition in
New Mexico’s ED dataset, resulting in a negative level change.
The extent to which level changes were affected by using various
ICD-9-CM indicator definitions may be related to the total number
of diagnostic fields available in the discharge dataset, which differs
by state (table 2). States with more available fields are excluding a
greater number of potential cases by using ICD-9-CM indicator
definitions that search only the principal/first-listed diagnosis field
or first-listed valid external cause field.24 34
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Table 4 Interrupted time series model regression parameters: opioid overdose emergency department (ED) visit and hospitalisation rates per
100 000 population using three different ICD-9-CM indicator definitions

Original research
We do not recommend generalising these results to other states
or nationally because our convenience sample of six states from
the CSTE DPI-
WG was not representative. We also caution
generalisation of these results to other drug overdose indicators
not specifically investigated in this study. Limitations of HDD
include the lack of personal identifiers, and the exemption of
federal facilities (Indian Health Services and Veterans Affairs)
from reporting. In addition, we did not explicitly control for
external factors that could affect the true incidence of drug
overdose, for example, increased federal and local funding for
prevention activities, introduction of the CDC guideline for
prescribing opioids for chronic pain,35 emergence of fentanyl
and other illicit drugs on the market, increases in take-home
naloxone prescribing, and other policy changes or state-specific
factors.

CONCLUSION

The transition from ICD-9-CM to ICD-10-CM appears to have
introduced major systematic differences in measurement of drug
overdoses such that data from the two coding systems should not
be interpreted as continuous. However, understanding that trend
data are paramount amid the current drug overdose epidemic, the
results of this study can be used to guide methodology for overdose surveillance and research employing ICD-coded ED visit or
hospitalisation data. Graphs presenting longitudinal data across
October 2015 should clearly indicate the ICD-10-CM transition with a vertical line and label. Statistical models of overdose
trends that incorporate data from both coding schemes should
include terms to control for the ICD-10-CM transition. Summary
statistics for the year 2015 should not combine data from both
ICD-9-CM and ICD-10-CM. Instead, consider reporting statistics for fiscal year 2015 (October 2014–September 2015) or the
first three quarters of calendar year 2015 only (January 2015–
September 2015). Lastly, it is important to consider the structural comparability of indicator definitions used to capture cases
under each coding system, both in terms of which codes are
included and which fields are searched.

What is already known on the subject
►► Epidemiologists rely on International Classification of

Diseases (ICD)-coded administrative claims data to monitor
drug overdose morbidity, a major public health problem.
►► Drug overdose coding went through substantial revision
in the transition from International Classification of
Diseases, 9th Revision, Clinical Modification (ICD-9-CM)
to International Classification of Diseases, 10th Revision,
Clinical Modification (ICD-10-CM).
►► Studies have begun to evaluate the impact of the transition
on surveillance of health outcomes.
What this study adds
►► This study uses interrupted time series methodology to

analyse the performance of all-drug and opioid overdose
indicators across the ICD transition in both ED and inpatient
datasets.
►► No other study has evaluated how adjusting the number of
diagnostic fields searched in ICD-9-CM indicator definitions
impacts trend comparability across the transition.
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